{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:54:42Z","timestamp":1790013282583,"version":"4.0.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1287,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1111\/j.1365-2133.2011.10716.x","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T13:13:44Z","timestamp":1320239624000},"page":"633-641","source":"Crossref","is-referenced-by-count":143,"title":["Once-daily topical brimonidine tartrate gel 0\u00b75% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies"],"prefix":"10.1093","volume":"166","author":[{"given":"J.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jarratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Steinhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Brimonidine Phase II Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,2,22]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea: I. Etiology, pathogenesis, and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB3|cit3","first-page":"419","article-title":"An epidemiological study of rosacea","volume":"69","author":"Berg","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-3083.2005.01216.x","article-title":"Rosacea and its management: an overview","volume":"19","author":"Gupta","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB5|cit5","first-page":"73","article-title":"The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea","volume":"79","author":"Wolf","year":"2007","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2010.09894.x","article-title":"The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities","volume":"163","author":"Aksoy","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaad.2004.01.048","article-title":"Standard grading system for rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB8|cit8","first-page":"43","article-title":"Standard management options for rosacea, Part I: overview and broad spectrum of care","volume":"84","author":"Odom","year":"2009","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB9|cit9","first-page":"97","article-title":"Standard management options for rosacea, Part II: option according to subtype","volume":"84","author":"Odom","year":"2009","journal-title":"Cutis"},{"issue":"Suppl. 4","key":"10.1111\/j.1365-2133.2011.10716.x-BIB10|cit10","first-page":"20","article-title":"Drug therapy of rosacea: a problem-directed approach","volume":"2","author":"Singer","year":"1998","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Rosacea","volume":"352","author":"Powell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1994.01690030091015","article-title":"Rosacea: pathophysiology and treatment","volume":"130","author":"Wilkin","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/09546630701485233","article-title":"The enigma of rosacea","volume":"18","author":"Marks","year":"2007","journal-title":"J Dermatol Treat"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","article-title":"Neurovascular and neuroimmune aspects in the pathophysiology of rosacea","volume":"15","author":"Schwab","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1517\/14740331003709736","article-title":"Brimonidine for glaucoma","volume":"9","author":"Rahman","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0002-9394(98)00286-4","article-title":"Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine study group","volume":"127","author":"Katz","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2011.10716.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0039-6257(96)82030-3","article-title":"A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The brimonidine study group III","volume":"41","author":"Serle","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000051725","article-title":"Topical metronidazole does not abate UVB-induced erythema","volume":"203","author":"Guarrera","year":"2001","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB20|cit20","first-page":"9","article-title":"Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity","volume":"34","author":"Graf","year":"1996","journal-title":"Rhiology"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00002512-199812030-00005","article-title":"Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension","volume":"12","author":"Adkins","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archopht.1997.01100160017002","article-title":"A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial","volume":"115","author":"Schuman","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","article-title":"Rosacea: II. Therapy","volume":"51","author":"Pelle","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/000155599750009915","article-title":"Stinging and rosacea","volume":"79","author":"Lonne-Rahm","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archderm.143.11.1369","article-title":"Successful treatment of the erythema and flushing of rosacea using a topically applied selective \u03b11-adrenergic receptor agonist, oxymetazoline","volume":"143","author":"Shanler","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0190-9622(89)70022-0","article-title":"Effect of nadolol on flushing reactions in rosacea","volume":"20","author":"Wilkin","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jaad.2005.07.021","article-title":"Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol","volume":"53","author":"Craige","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"H1075","DOI":"10.1152\/ajpheart.2000.278.4.H1075","article-title":"Silent \u03b12C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries","volume":"278","author":"Chotani","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1111\/j.1365-2133.2011.10716.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/1529-0131(200008)43:8<1886::AID-ANR27>3.0.CO;2-S","article-title":"Increased \u03b12-adrenergic constriction of isolated arterioles in diffuse scleroderma","volume":"43","author":"Flavahan","year":"2000","journal-title":"Arthritis Rheum"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10716.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10716.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:54:05Z","timestamp":1676364845000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/166\/3\/633\/6613643"}},"subtitle":["Brimonidine tartrate in the treatment of erythema of rosacea"],"short-title":[],"issued":{"date-parts":[[2012,2,22]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10716.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14263033.15775159","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.14263033.15779083","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.14263033.15777067","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2,22]]}}}